Bank of New York Mellon »

Bioxcel Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $347k 123k 2.82
2023-12-31 $373k 127k 2.95
2023-09-30 $324k 128k 2.53
2023-06-30 $753k 113k 6.66
2023-03-31 $1.4M 77k 18.66
2022-12-31 $1.5M 72k 21.48
2022-09-30 $824k 65k 12.63
2022-06-30 $802k 61k 13.18
2022-03-31 $1.2M 58k 20.87
2021-12-31 $1.1M 57k 20.00
2021-09-30 $1.6M 54k 30.36
2021-06-30 $1.4M 50k 29.07
2021-03-31 $2.6M 61k 43.13
2020-12-31 $2.9M 62k 46.20
2020-09-30 $2.4M 56k 43.34
2020-06-30 $2.8M 53k 52.63
2020-03-31 $1.1M 50k 22.38
2019-12-31 $284k 19k 14.61
2019-09-30 $142k 19k 7.31
2019-06-30 $198k 18k 10.96